关于
  • English
  • About
    • Management
    • Board of Directors
    • Strategic Advisory Board
    • Our Partners
  • TFChem
    • About TFChem
    • Management
    • Team
    • TFChem Laboratory Capabilities
  • Programs
    • Proprietary Platform Technology
    • Pipeline
    • Diabetes – SGLT2 Inhibitor
    • Skincare – Dark Spot Correction
    • Skincare – Anti-Aging / Anti-Wrinkle
    • Antiviral
  • News
    • Sirona News
    • Events
  • Investors
    • Financial Information
    • Financial Reports
    • Investor & Media Kit
    • Newsletter
  • Contact
  • Careers

Financial Reports

2023
  • MD&A Q3 31 July 2023
  • FS Q3 31 July 2023
  • MD&A Q2 30 Apr 2023
  • FS Q2 30 Apr 2023
  • MD&A Q1 31 Jan 2023
  • FS Q1 31 Jan 2023
2022
  • MD&A Year End 31 Oct 2022
  • FS Year End 31 Oct 2022
  • MD&A 31 Jul 2022
  • FS Q3 31 Jul 2022
  • MD&A Q2 30 Apr 2022
  • FS Q2 30 Apr 2022
  • MD&A Q1 31 Jan 2022
  • FS Q1 31 Jan 2022
2021
  • MD&A Year End 31 Oct 2021
  • FS Year End 31 Oct 2021
  • MD&A 31 Jul 2021
  • FS Q3 31 Jul 2021
  • MD&A Q2 30 Apr 2021
  • FS Q2 30 Apr 2021
  • MD&A Q1 31 Jan 2021
  • FS Q1 31 Jan 2021
2020
  • MD&A Year End 31 Oct 2020
  • FS Year End 31 Oct 2020
  • MD&A 31 Jul 2020
  • FS Q3 31 Jul 2020
  • MD&A Q2 30 Apr 2020
  • FS Q2 30 Apr 2020
  • MD&A Q1 31 Jan 2020
  • FS Q1 31 Jan 2020
2019
  • MD&A Year End 31 Oct 2019
  • FS Year End 31 Oct 2019
  • MD&A Q3 31 Jul 2019
  • FS Q3 31 Jul 2019
  • MD&A Q2 30 Apr 2019
  • FS Q2 30 Apr 2019
  • MD&A Q1 31 Jan 2019
  • FS Q1 31 Jan 2019
2018
  • MD&A Year End 31 Oct 2018
  • FS Year End 31 Oct 2018
  • MD&A Q3 31 Jul 2018
  • FS Q3 31 Jul 2018
  • MD&A Q2 30 Apr 2018
  • FS Q2 30 Apr 2018
  • MD&A Q1 31 Jan 2018 
  • FS Q1 31 Jan 2018
2017
  • MD&A Year End 31 Oct 2017
  • FS Year End 31 Oct 2017
  • MD&A Q3 31 July 2017
  • FS Q3 31 July 2017
  • MD&A Q2 30 Apr 2017
  • FS Q2 30 Apr 2017
  • MD&A Q1 31 Jan 2017
  • FS Q1 31 JAN 2017
2016
  • MD&A Year End 31 Oct 2016
  • FS Year End 31 Oct 2016
  • MD&A Q3 31 Jul 2016
  • FS Q3 31 Jul 2016
  • MD&A Q2 30 Apr 2016
  • FS Q2 30 Apr 2016
  • MD&A Q1 31 Jan 2016
  • FS Q1 31 Jan 2016
  • About
  • TFChem
  • Programs
  • News
  • Investors
  • Contact

© 2023 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

© 2023 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

Enter your info below to subscribe to our newsletter:
Loading